A

Active Director Director DIN 10360925
DIN 10360925 First appointment Oct 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay

Data last updated:

Akshay is a Director at Emplex Pharma Private Limited (since 2025) and Director at Zedx Healthcare Private Limited (since 2023). The companies operate in Paper.

DIN 10360925
Primary Designation Director
Industry Paper
First Appointment 18 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emplex Pharma Private Limited U21000UP2025PTC218062
Director01 Mar 20252025Active
Zedx Healthcare Private Limited U21009MH2023PTC412416
Director18 Oct 20232023Active

Board colleagues of Akshay

Directorship timeline

Open interactive timeline →
Emplex Pharma Private Limited
Zedx Healthcare Private Limited
Premium access

Shareholding and investment profile for Akshay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay

Akshay currently holds 2 directorships: Emplex Pharma Private Limited (Director, since 01 Mar 2025); Zedx Healthcare Private Limited (Director, since 18 Oct 2023).

Akshay was first appointed on 18 Oct 2023 as Director at Zedx Healthcare Private Limited. The most recent appointment on record is 01 Mar 2025 at Emplex Pharma Private Limited.

The current boards of Akshay's companies include Ansh Gupta (Emplex Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available